Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
13 pending office actions • 11 art units • 13 examiners • 0 of 13 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
University of Copenhagen has 12 pending office actions. These are in the Biotechnology & Pharmaceuticals technology area and are distributed across 10 distinct art units. This high ratio of art units to pending actions suggests that the university's biotech portfolio is technically diverse, touching on many different specialized classifications within the patent office.
The prosecution involves 12 distinct examiners. HAI Y ZHANG is the busiest examiner, with 1 pending office action. With 12 pending actions and 12 examiners, each examiner is responsible for exactly one matter. This distribution means that the university's prosecution strategy must account for 12 different examiner approaches. The presence of 10 art units further emphasizes that these 12 examiners are working within many different technical frameworks, requiring a broad and varied approach to managing the active docket.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (15%) |
| §103 only | 1 (8%) |
| §102 only | 2 (15%) |
| §112 only | 2 (15%) |
| Double-patenting + other | 2 (15%) |
| Multi-statute (no §101) | 4 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHANG, HAI Y | 1 | 68.7% | +42.6% |
| SAIDHA, TEKCHAND | 1 | 82.9% | +14.1% |
| BARRETT, RYAN S | 1 | 65.5% | +41.2% |
| STEELE, AMBER D | 1 | 58.9% | +9.3% |
| STECKBAUER, KEVIN R | 1 | 82.0% | +7.7% |
| TRAN, KHOA NHAT | 1 | 43.2% | +53.3% |
| SCHLIENTZ, LEAH H | 1 | 41.9% | +38.5% |
| SHOMER, ISAAC | 1 | 63.2% | +30.4% |
| CHEN, STACY BROWN | 1 | 66.1% | +40.6% |
| KWON, JOHN SEUNGJAI | 1 | 45.7% | +19.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18555892 | A SYSTEM AND A METHOD OF DETERMINING INFORMATION RELATING TO A PERIODIC SIGNAL | STECKBAUER, KEVIN R | 19d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | SCHLIENTZ, LEAH H | 39d |
| 18873862 | Stencil mask and use thereof in lithography fabrication | ZHANG, HAI Y | — |
| 18721990 | IMPROVED HEPARAN SULFATE AND METHODS OF MAKING THE SAME | SAIDHA, TEKCHAND | — |
| 18564398 | PEPTIDES DERIVED FROM RUMINOCOCCUS TORQUES | STEELE, AMBER D | — |
| 18038044 | CRISPR/CAS SCREENING SYSTEM MATERIALS AND METHODS | TRAN, KHOA NHAT | — |
| 17768525 | Agonist of Tacr2 | BEANE, RANDALL L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17968115 | VIRUS-LIKE PARTICLE WITH EFFICIENT EPITOPE DISPLAY | CHEN, STACY BROWN | 164d overdue |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | SCHLIENTZ, LEAH H | 39d |
| 18873862 | Stencil mask and use thereof in lithography fabrication | ZHANG, HAI Y | — |
| 18721990 | IMPROVED HEPARAN SULFATE AND METHODS OF MAKING THE SAME | SAIDHA, TEKCHAND | — |
| 18683341 | A METHOD OF MANIPULATING A QUBIT AND AN ASSEMBLY COMPRISING A QUBIT | BARRETT, RYAN S | — |
| 18038044 | CRISPR/CAS SCREENING SYSTEM MATERIALS AND METHODS | TRAN, KHOA NHAT | — |
| 18166339 | CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN | SHOMER, ISAAC | — |
| 17907455 | A FLEXIBLE FOIL FOR THE DELIVERY OF THERAPEUTIC CARGOS | KWON, JOHN SEUNGJAI | — |
| Art Unit | Apps |
|---|---|
| 1654 | 2 |
| 1717 | 1 |
| 1652 | 1 |
| 1658 | 1 |
| 3747 | 1 |
| 1632 | 1 |
| 1618 | 1 |
| 1612 | 1 |
| 1672 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18873862 | Stencil mask and use thereof in lithography fabrication | ZHANG, HAI Y | 1717 | §103§112 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18721990 | IMPROVED HEPARAN SULFATE AND METHODS OF MAKING THE SAME | SAIDHA, TEKCHAND | 1652 | §102§112 | Non-Final OA | — | Pending | Jun 20, 2024 |
| 18683341 | A METHOD OF MANIPULATING A QUBIT AND AN ASSEMBLY COMPRISING A QUBIT | BARRETT, RYAN S | — | §102Other | Non-Final OA | — | Pending | Feb 13, 2024 |
| 18564398 | PEPTIDES DERIVED FROM RUMINOCOCCUS TORQUES | STEELE, AMBER D | 1658 | §101§112 | Non-Final OA | — | Pending | Nov 27, 2023 |
| 18555892 | A SYSTEM AND A METHOD OF DETERMINING INFORMATION RELATING TO A PERIODIC SIGNAL | STECKBAUER, KEVIN R | 3747 | §102 | Non-Final OA | 19d overdue | Pending | Oct 18, 2023 |
| 18038044 | CRISPR/CAS SCREENING SYSTEM MATERIALS AND METHODS | TRAN, KHOA NHAT | 1632 | §101§103§112 | Final Rejection | — | Pending | May 22, 2023 |
| 18041827 | EXTRACORPOREAL CLEARING TRAPS BASED ON INVERSE ELECTRON DEMAND DIELS-ALDER CYCLOADDITION FOR (PRE)-TARGETED THERAPY AND DIAGNOSTICS | SCHLIENTZ, LEAH H | 1618 | §103§112 | Non-Final OA | 39d | Pending | Feb 16, 2023 |
| 18166339 | CO-AMORPHOUS FORM OF A SUBSTANCE AND A PROTEIN | SHOMER, ISAAC | 1612 | DPOther | Non-Final OA | — | Pending | Feb 08, 2023 |
| 17968115 | VIRUS-LIKE PARTICLE WITH EFFICIENT EPITOPE DISPLAY | CHEN, STACY BROWN | 1672 | §112DP | Non-Final OA | 164d overdue | Pending | Oct 18, 2022 |
| 17907455 | A FLEXIBLE FOIL FOR THE DELIVERY OF THERAPEUTIC CARGOS | KWON, JOHN SEUNGJAI | 1615 | §103 | Final Rejection | — | Pending | Sep 27, 2022 |
| 17768525 | Agonist of Tacr2 | BEANE, RANDALL L | 1654 | §102§103 | Final Rejection | — | Pending | Apr 13, 2022 |
| 17283995 | VIRALLY EXPRESSED INHIBITORS OF PDZ DOMAINS, SUCH AS PICK1 AND USES THEREOF | ZAHORIK, AMANDA MARY | 1636 | §112 | Non-Final OA | — | Pending | Apr 09, 2021 |
| 17188805 | GIP PEPTIDE ANALOGUES | DABKOWSKI, ERINNE R | 1654 | §112Other | Final Rejection | 29d | Pending | Mar 01, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial